KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Receivables (2020 - 2025)

Organon (OGN) has 6 years of Receivables data on record, last reported at $1.3 billion in Q4 2025.

  • For Q4 2025, Receivables fell 1.99% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, down 1.99%, while the annual FY2025 figure was $1.3 billion, 1.99% down from the prior year.
  • Receivables reached $1.3 billion in Q4 2025 per OGN's latest filing, down from $1.5 billion in the prior quarter.
  • Across five years, Receivables topped out at $2.5 billion in Q2 2021 and bottomed at $1.0 billion in Q1 2021.
  • Average Receivables over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2022.
  • The widest YoY moves for Receivables: up 66.34% in 2022, down 23.22% in 2022.
  • A 5-year view of Receivables shows it stood at $1.8 billion in 2021, then increased by 3.59% to $1.8 billion in 2022, then decreased by 5.68% to $1.7 billion in 2023, then dropped by 22.13% to $1.4 billion in 2024, then dropped by 1.99% to $1.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $1.3 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.5 billion in Q2 2025.